Anemia of chronic disease.

@article{Weiss2005AnemiaOC,
  title={Anemia of chronic disease.},
  author={Guenter Weiss and Lawrence T Goodnough},
  journal={The New England journal of medicine},
  year={2005},
  volume={352 10},
  pages={
          1011-23
        }
}
New therapeutic strategies have emerged along with our understanding that disturbances of iron homeostasis, impaired proliferation of erythroid progenitor cells, and blunted erythropoietin response occur in anemia of chronic disease. This review discusses advances in our knowledge of the causes and management of the condition. 
View on PubMed
aging.arizona.edu
1,896 Citations
Highly Influential Citations
89
Background Citations
460
Methods Citations
23
Results Citations
19

Figures, Tables, and Topics from this paper

1,896 Citations

Citation Type

Citation Type

Elucidating the role of monocyte-derived hepcidin.
To the editor: Anemia of chronic disease is an important cause of morbidity in patients suffering from chronic inflammatory states and has been rechristened anemia of inflammation with the onset of…
ANEMIA OF CHRONIC DISEASE
TLDR
Main causes, pathogenesis, clinical manifestation of anemia of chronic disease and basic approaches to its diagnostics and treatment are described.
Hematologic parameters predicting a response to oral iron therapy in chronic inflammation
In anemic patients with chronic inflammatory conditions, the assessment of iron status and the selection of those who may benefit from iron therapy frequently presents diagnostic…
Anemia of Inflammation in Critically Ill Patients
TLDR
The causes of anemia are reviewed with an emphasis on the effects of inflammation, the risks and benefits of current therapies are examined, and novel treatment options are discussed.
Erythropoietin Response in Patients with Anaemia of Chronic Disorders
TLDR
The aim of the study was to determine the appropriateness of erythropoietin response to anemia observed in chronic disease.
Transferrin as a Possible Treatment for Anemia of Inflammation in the Critically Ill
Previously termed ‘anemia of chronic diseases’, anemia developing as a consequence of inflammation is now called anemia of inflammation. In this chapter, we describe the prevalence and etiology of…
Iron-deficiency anemia.
TLDR
The global nature of the disease, iron homeostasis in normal and iron-deficient states, clinical findings, treatment, and causes of iron-resistant iron deficiency are reviewed.
Therapeutic Opportunities for Hepcidin in Acute Care Medicine.
Chapter 2 – Hematologic Manifestations of Systemic Illness
Is anemia in chronic heart failure caused by iron deficiency?
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 112 REFERENCES
Anemia of inflammation: the cytokine-hepcidin link.
  • N. Andrews
  • Medicine, Biology
    The Journal of clinical investigation
  • 2004
TLDR
It now appears that the inflammatory cytokine IL-6 induces production of hepcidin, an iron-regulatory hormone that may be responsible for most or all of the features of this disorder.
Iron therapy and cardiovascular disease.
  • J. Sullivan
  • Medicine
    Kidney international. Supplement
  • 1999
TLDR
The history and current status of the "iron hypothesis" on ischemic heart disease are briefly reviewed, followed by comments on iron management practices for renal patients.
High dose intravenous iron: a note of caution.
  • J. Kletzmayr, G. Sunder-Plassmann, W. Hörl
  • Medicine, Biology
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • 2002
TLDR
Iron supplementation is needed to prevent hyporesponsiveness to rhuEpo or NESP therapy, and is not without sideeffects, particularly if high dose intravenous (i.v.) iron is administered.
Regulation of ferritin genes and protein.
TLDR
Changes in ferritin are important not only in the classic diseases of iron acquisition, transport, and storage, but also in diseases such as primary hemochromatosis.
Anemia management in chronic kidney disease: role of factors affecting epoetin responsiveness.
  • J. Eschbach
  • Medicine
    Journal of the American Society of Nephrology : JASN
  • 2002
TLDR
The article by Coladonato et al. notes an encouraging increase in mean hematocrit levels between 1994 and 1998, an increase into the target range recommended by the 1997 and 2000 DOQI Anemia.
Recent developments in the anemia of chronic disease.
  • R. Means
  • Medicine, Biology
    Current hematology reports
  • 2003
The anemia of chronic disease (ACD) is a hypoproliferative anemia defined by a low serum or plasma iron concentration in the presence of adequate reticuloendothelial iron stores. It is been…
A clinical evaluation of serum ferritin as an index of iron stores.
Abstract Measurements of serum ferritin were correlated with other hematologic laboratory indexes in 250 hospitalized subjects with anemia or disorders in iron metabolism. A geometric mean value of...
Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction?
TLDR
Allogeneic blood transfusion results in the infusion into the recipient of large amounts of foreign antigens in both soluble and cell-associated forms, which may create conditions that allow the development of immune down-regulation.
Iron and the anemia of chronic disease.
TLDR
It has become apparent that disordered iron metabolism, while characteristic of this form of anemia, may not be central to its pathogenesis, and refutes the concept that the lack of available iron is central to the pathogenesis of the syndrome.
Anemia, transfusion, and mortality.
Questions surrounding the risks and costs associated with blood transfusion have led to a reevaluation of clinical transfusion practices during the past 15 years.1 Guidelines for blood transfusion ...
...
1
2
3
4
5
...